Amphastar Pharmaceuticals (AMPH) Shares Outstanding (Diluted Average) (2013 - 2016)
Amphastar Pharmaceuticals (AMPH) recorded quarterly Shares Outstanding (Diluted Average) of $45.7 million in Q2 2016, down 2.35% quarter-over-quarter from $46.8 million in Q1 2016, and up 1.92% on a YoY basis from $44.8 million in Q3 2015.
Amphastar Pharmaceuticals (AMPH) Shares Outstanding (Diluted Average) (2013 - 2016) Analysis & Trends
Amphastar Pharmaceuticals' Shares Outstanding (Diluted Average) history runs 4 years deep, the most recent figure standing at $45.7 million for Q2 2016.
- In Q2 2016, Shares Outstanding (Diluted Average) rose 1.92% year-over-year to $45.7 million; the TTM figure through Jun 2016 stood at $45.7 million (up 1.92% YoY), while the FY2015 annual figure was $45.0 million, changed N/A from the prior year.
- Shares Outstanding (Diluted Average) was $45.7 million for Q2 2016 at Amphastar Pharmaceuticals, down from $46.8 million in the prior quarter.
- In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $46.8 million in Q1 2016 to a low of $38769.0 in Q1 2014.
- Historically, Shares Outstanding (Diluted Average) has averaged $28.6 million across 4 years, with a median of $38.9 million in 2013.
- The sharpest annual moves came in 2014 and 2015: Shares Outstanding (Diluted Average) sank 99.9% in 2014, then soared 114942.95% in 2015.
- A 4-year view of Shares Outstanding (Diluted Average) shows it stood at $38.9 million in 2013, then sank by 99.89% to $44644.0 in 2014, then soared by 100610.06% to $45.0 million in 2015, then rose by 1.67% to $45.7 million in 2016.
- The last three Shares Outstanding (Diluted Average) figures came in at $45.7 million (Q2 2016), $46.8 million (Q1 2016), and $45.0 million (Q4 2015), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 1.18 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 422.40 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 47.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 103.40 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 506.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 228.36 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Amphastar Pharmaceuticals | 914.14 Mn | 914.14 Mn | 70.32 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2016 | 45.71 Mn |
| Mar 31, 2016 | 46.81 Mn |
| Dec 31, 2015 | 44.96 Mn |
| Sep 30, 2015 | 45,310.00 |
| Jun 30, 2015 | 44.85 Mn |
| Mar 31, 2015 | 44.60 Mn |
| Sep 30, 2014 | 44,644.00 |
| Jun 30, 2014 | 39,767.00 |
| Mar 31, 2014 | 38,769.00 |
| Dec 31, 2013 | 38.88 Mn |
| Sep 30, 2013 | 38.71 Mn |
| Jun 30, 2013 | 38.85 Mn |